Cemex to Divest Colombian Operations for $555M, Streamlining Portfolio
CX has more than doubled off its 52-week low of $4.89.
Summary
Cemex announced the divestment of a significant portion of its operations in Colombia for approximately $555 million, a strategic move to streamline its portfolio and focus on core markets.
Key Events · M&A and Partnerships · CX
-
Divestment of Colombian Operations
Cemex is divesting a portion of its operations in Colombia for a combined purchase price of approximately US$555 million.
-
Strategic Portfolio Streamlining
The divestment is part of Cemex's ongoing strategy to streamline its portfolio and focus investments on key geographies and businesses in the U.S., Europe, and Mexico, aligning with its 'Project Cutting Edge' strategic plan.
-
Agreement with Holcim Group
As a first step, Cemex entered an agreement with Holcim Group to sell a cement plant, a grinding mill, and a portfolio of ready-mix concrete, aggregates, mortar, and admixture plants for US$485 million.
-
Additional Asset Sales
Cemex is negotiating with other third parties for the sale of remaining assets in the same geographic area, expected to generate an additional US$70 million.
Analysis · CX · Manufacturing
This divestment represents a substantial strategic shift for Cemex, allowing the company to rebalance its portfolio and concentrate investments in key growth regions like the U.S., Europe, and Mexico. The sale, valued at $555 million and an approximate 10x 2025 EBITDA multiple, provides significant capital that can be redeployed or used to strengthen the balance sheet. While reducing its presence in Colombia, Cemex will retain core assets to continue serving the market, indicating a focused rather than complete exit. This move aligns with the company's previously announced "Project Cutting Edge" strategic plan, emphasizing efficiency and targeted growth.
At the time of this filing, CX was trading at $10.56 on NYSE in the Manufacturing sector, with a market capitalization of approximately $16.1B. The 52-week trading range was $4.89 to $13.35. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.